Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzuken Co ( (JP:9987) ) just unveiled an announcement.
Suzuken Co., Ltd. has reported the repurchase of 539,400 of its own shares during October 2025, amounting to approximately ¥3.16 billion. This action is part of a larger share repurchase program announced in May 2025, which allows for the repurchase of up to 5.2 million shares by March 2026. The ongoing repurchase strategy is aimed at enhancing shareholder value and optimizing the company’s capital structure.
The most recent analyst rating on (JP:9987) stock is a Buy with a Yen6800.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, primarily focusing on the distribution of pharmaceutical products and healthcare-related services. The company is listed on the Prime Markets of the Tokyo and Nagoya Stock Exchanges, as well as the Sapporo Securities Exchange.
Average Trading Volume: 182,727
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.4B
See more data about 9987 stock on TipRanks’ Stock Analysis page.